Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rap guanine nucleotide exchange factor (GEF) 4 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | N-terminal motif family protein | Get druggable targets OG5_131726 | All targets in OG5_131726 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | Get druggable targets OG5_131726 | All targets in OG5_131726 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131726 | All targets in OG5_131726 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0401 | 0.1581 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.2538 | 0.2538 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2538 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2538 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0401 | 0.1581 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0401 | 0.1581 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.2538 | 0.2538 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0401 | 0.1581 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2387 | 0.2387 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.2538 | 0.2538 |
Onchocerca volvulus | 0.0151 | 0.6771 | 0.6771 | |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.2538 | 0.2538 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.2538 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2538 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0401 | 0.1581 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0401 | 0.0401 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.6771 | 0.6771 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1468 | 0.1468 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0401 | 0.1581 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0401 | 0.0401 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0218 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0063 | 0.2538 | 0.2538 |
Toxoplasma gondii | hypothetical protein | 0.0011 | 0 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0401 | 0.0401 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2387 | 0.2387 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0401 | 0.1581 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2538 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0401 | 0.1581 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2387 | 0.2387 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2387 | 0.2387 |
Brugia malayi | hypothetical protein | 0.0151 | 0.6771 | 0.6771 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0401 | 0.0401 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.2538 | 0.2538 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2538 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1468 | 0.1468 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.2538 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1468 | 0.5783 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0401 | 0.1581 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0401 | 0.1581 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.